PAPER Koh JT, Lee ZH, Ahn KY, Kim JK, Bae CS, Kim HH, Kee HJ, Kim KK
SEARCH RESULTS
330913 RESULTS
Min Zhang
Abbvie
Magnus Rogeberg
Akershus University HospitalNorway
PAPER Ross AJ, Sachdev PS, Wen W, Brodaty H, Joscelyne A, Lorentz LM
Prediction of cognitive decline after stroke using proton magnetic resonance spectroscopy.
J Neurol Sci. 2006 Dec 21;251(1-2):62-9. Epub 2006 Nov 7 PubMed: 17092517Nicola Filippini
University of OxfordUnited Kingdom
Beryl van Hoek
Debby Tsuang
University of WashingtonSeattle, United States
Anne Urfer-Buchwalder
Selonterra LLC
Astrocytes Agitate Neurons in Huntington’s Disease
RESEARCH NEWS 2014-03-31 Research News Studies of neurodegenerative disease often overlook astrocytes, the glial cells that surround and nurture neurons. For some years, evidence has grown to suggest they play an important role. Now, in the March 30 Nature Neuroscience, researche
PAPER Girouard H, Bonev AD, Hannah RM, Meredith A, Aldrich RW, Nelson MT
Astrocytic endfoot Ca2+ and BK channels determine both arteriolar dilation and constriction.
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3811-6. Epub 2010 Feb 2 PubMed: 20133576PAPER Puwarawuttipanit W, Bragg AD, Frydenlund DS, Mylonakou MN, Nagelhus EA, Peters MF, Kotchabhakdi N, Adams ME, Froehner SC, Haug FM, Ottersen OP, Amiry-Moghaddam M
Differential effect of alpha-syntrophin knockout on aquaporin-4 and Kir4.1 expression in retinal macroglial cells in mice.
Neuroscience. 2006;137(1):165-75. Epub 2005 Oct 28 PubMed: 16257493PAPER Barres BA, Koroshetz WJ, Chun LL, Corey DP
Ion channel expression by white matter glia: the type-1 astrocyte.
Neuron. 1990 Oct;5(4):527-44. PubMed: 1698397PAPER Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, Dufour N, Guillermier M, Brouillet E, Hantraye P, Déglon N, Ferrante RJ, Bonvento G
In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
Hum Mol Genet. 2010 Aug 1;19(15):3053-67. Epub 2010 May 21 PubMed: 20494921Coenzyme Q10 Strikes Out in Phase 3 for Parkinson’s
RESEARCH NEWS 2014-03-31 Research News Coenzyme Q10 treatment does not slow the progression of Parkinson’s disease (PD). This was the disappointing conclusion of a Phase 3 clinical trial designed to test the disease-modifying potential of the drug. CoQ10 is an antioxidant that su
PAPER Yang L, Zhao K, Calingasan NY, Luo G, Szeto HH, Beal MF
Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity.
Antioxid Redox Signal. 2009 Sep;11(9):2095-104. PubMed: 19203217Current Filters
No filters selected